Navigation Links
23andMe and mondoBIOTECH Partner to Advance Research of Rare Diseases
Date:1/28/2009

ble information for identifying treatment protocols.

"We are eager to take an active role in advancing research of rare genetic disorders," said Linda Avey, co-founder of 23andMe. "By partnering with our colleagues at mondoBIOTECH, a company acutely focused in this area, we'll be able to leverage the genetics and bioinformatics expertise of our science team toward better understanding of these often devastating conditions."

"For years, we have been working on behalf of neglected and underserved disease communities to help improve the lives of people with rare and fatal diseases," said Fabio Cavalli, Chief Executive Officer of mondoBIOTECH. "When we met the founders of 23andMe last year at Davos and saw what they were doing with genetics, we knew that a collaboration between the two companies could go a long way towards understanding the causes of the diseases we have been researching."

About 23andMe

23andMe, Inc. is the leading personal genetics company dedicated to helping individuals understand their own genetic information through DNA analysis technologies and web-based interactive tools. The company's Personal Genome Service(TM) enables individuals to gain deeper insights into their ancestry and inherited traits. 23andMe, Inc., was founded by Linda Avey and Anne Wojcicki in 2006, and the company is advised by a group of renowned experts in the fields of human genetics, bioinformatics and computer science. Its Series A investors include Genentech, Inc., Google Inc. and New Enterprise Associates. More information is available at www.23andme.com

About mondoBIOTECH

mondoBIOTECH is the Swiss open source biotech aiming to improve the health of patients affected by rare diseases. mondoBIOTECH currently has a product pipeline of more than 300 peptides as treatment options for more than 600 rare diseases. The com
'/>"/>

SOURCE 23andMe, Inc.; mondoBIOTECH AG
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. 23andMe Announces Breast Cancer Initiative
2. The World Economic Forum Announces Technology Pioneers 2008: Mondobiotech Selected
3. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
4. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
5. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
6. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
9. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
11. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015  MiMedx Group, Inc. (NASDAQ: ... amniotic tissue and patent-protected processes to develop and market ... Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of ... "Pete" Petit, has been awarded the Lifetime Achievement Award ... Program. The Entrepreneur Of The Year ...
(Date:6/29/2015)... , June 29, 2015   Veracyte, Inc ... pioneering the field of molecular cytology, today announced that ... Group,s prestigious Top Workplaces list for the second year ... winners based solely on an annual survey of Bay ... honored that the degree to which Veracyte values our ...
(Date:6/26/2015)... , June 26, 2015   ... ), a pet therapeutics company focused on ... biopharmaceutical products for companion animals, today announced ... study of capromorelin (AT-002), the company,s innovative ... is a small molecule that mimics ghrelin, ...
(Date:6/26/2015)... and MUMBAI, India , June ... NSE: TCS) a leading global IT services, consulting and ... as a Leader in Worldwide Life Sciences R&D Risk-Based ... " IDC MarketScape: Worldwide Life Science R&D Risk-Based Monitoring ... The report evaluated eight leading IT services ...
Breaking Biology Technology:EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4
... Metabolic Solutions Development Company (MSDC), a drug discovery and ... diseases, announced today that it has received a $773,000 ... conduct a pilot Phase 2a trial of MSDC-0160, MSDC,s ... with altered mitochondrial function. "This funding ...
... 2011 Reportlinker.com announces that a new market ... Biobanking: Technologies and Global Markets ... REPORT HIGHLIGHTS THIS REPORT ... biobanks by types: Population, Disease, and Private Sector ...
... and Nottingham and using nanotechnology 100,000 times smaller than the ... harnessing the vast energy of the Sun to produce clean ... Royal Society,s annual Summer Science Exhibition which opens ,today [5 ... UEA have already found a way to produce hydrogen from ...
Cached Biology Technology:Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a Trial 2Metabolic Solutions Development Company Receives $773,000 From the Alzheimer's Drug Discovery Foundation to Fund Phase 2a Trial 3Biobanking: Technologies and Global Markets 2Biobanking: Technologies and Global Markets 3Biobanking: Technologies and Global Markets 4Biobanking: Technologies and Global Markets 5Biobanking: Technologies and Global Markets 6Biobanking: Technologies and Global Markets 7Biobanking: Technologies and Global Markets 8Biobanking: Technologies and Global Markets 9Biobanking: Technologies and Global Markets 10Biobanking: Technologies and Global Markets 11Biobanking: Technologies and Global Markets 12Biobanking: Technologies and Global Markets 13Putting sunshine in the tank 2
(Date:6/24/2015)... , June 24, 2015 Biometry authentication ... emerging biometric password solution one face in. ... one face in, entering the expanding ... and affordable multifactor-authentication biometric answer to the password ... provided in partnership with KeyLemon, one face in ...
(Date:6/23/2015)... , June 22, 2015 ... announced the addition of the "Body-Worn Temperature ... Growth, Trends and Forecast 2014 - 2020" ... offers strategic analysis of the global body-worn temperature ... has been segmented on the basis of types, ...
(Date:6/23/2015)... BEACH GARDENS, Fla. , June 23, ... multi-factor identity management and authentication solutions, today announced ... Altus strong, multi-factor authentication solution.  The enhancements ... of use of the DigitalPersona Altus platform ... biometric reader compatibility. In today,s ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2Crossmatch Releases Enhanced DigitalPersona Altus Advanced Authentication Functionality 2
... cyclones churned across the top of the world each year, leaving ... ice in the Arctic Ocean. That,s about 40 percent more ... study of vast troves of weather data that previously were synthesized ... in the number of cyclones could be important to anyone who ...
... health professionals will attend SIR 2014, the world,s ... benefits patients with image-guided, minimally invasive medicine. ... artery embolization, renal denervation, robotics and ablative cancer ... conference showcasing current research Monday, ,March 24. ...
... Jan. 16, 2014 -- Using a camera-equipped robot to ... and engineers with the Antarctic Geological Drilling (ANDRILL) Program ... of small sea anemones were burrowed into the underside ... water like flowers on a ceiling. , "The ...
Cached Biology News:Arctic cyclones more common than previously thought 2Arctic cyclones more common than previously thought 3Arctic cyclones more common than previously thought 4Ice-loving sea anemones discovered in Antarctica 2Ice-loving sea anemones discovered in Antarctica 3
...
Request Info...
... This DuoSet ELISA Development kit contains the ... sandwich ELISAs to measure natural and recombinant ... and serum. Each kit contains sufficient materials ... plates, provided that the following conditions are ...
Conjugation services for Antibodies, Proteins, Oligos, Peptides, Beads, bioconjugation, antibody-oligonucleotide, LNA peptide, LNA protein, LNA antibody, HRP, Alkaline phosphatase, phycoerythrin, FIT...
Biology Products: